Share on StockTwits

Cannabis Science (NASDAQ:CBIS) major shareholder Robert Melamede sold 425,800 shares of Cannabis Science stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $0.17, for a total value of $72,386.00. Following the transaction, the insider now directly owns 45,340,333 shares of the company’s stock, valued at approximately $7,707,857. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Cannabis Science (NASDAQ:CBIS) traded up 1.61% during mid-day trading on Friday, hitting $0.1829. 25,231,312 shares of the company’s stock traded hands. Cannabis Science has a 1-year low of $0.033 and a 1-year high of $0.12. The stock has a 50-day moving average of $0.04 and a 200-day moving average of $0.04. The company’s market cap is $139.2 million.

Cannabis Science, Inc is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.